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With increasing frequency, consumers are asked toevaluate product risk information (i.e., informa-tion that product use may lead to negative conse-
quences). For example, advertisements for tobacco products
have long been required to disclose the health hazards asso-
ciated with their use, and promotional materials for finan-
cial investments often contain caveats about potential finan-
cial losses (Fitch 1997; Fox et al. 1998). However, the most
dramatic growth in advertised product risk disclosures has
come from a relatively new category of advertising: direct-
to-consumer (DTC) advertisements for complex medical
products. Over the past 15 years, there has been an explo-
sion of such advertising; total expenditures on DTC pre-
scription drug advertising has grown more than 200-fold,
from $12 million in 1989 to more than $3 billion in 2003
(Calfee 2002; Thomaselli 2004). Most such advertising is
required to contain information on product risks. However,
as Cohen (2002, p. 172) notes, there is “continuing concern
that consumers may not adequately comprehend the bene-
fits and risks of using such highly technical products.”
There are two kinds of product risk information that
consumers may consider when evaluating such products.
First, there are product risk disclosures (i.e., explicit state-
ments of the potential adverse outcomes resulting from
product use). For example, Food and Drug Administration
rules require that any DTC advertisement that mentions
both the name of a prescription drug (e.g., Celebrex) and its
function (e.g., treatment of osteoarthritis) must also contain
information on product side-effect risk—that is, the possi-
bility of unintended physical harm (ranging from temporary
discomfort to permanent disability or even death) resulting
from product use (for discussions of the rules governing
such risk disclosures, see Calfee 2002; Menon et al. 2003b).
Second, consumers may also make inferences about the
risks of specific products, even when those risks are not
explicitly stated. For example, a consumer may perceive
that certain product forms (e.g., injections, radiological
scanning) entail inherent risks. In addition, a growing num-
ber of researchers have suggested that consumers perceive
certain product functions (e.g., problem detection) as inher-
ently riskier than others (see Meyerowitz and Chaiken
1987; Rothman and Salovey 1997).
It is important for marketers and policy makers to
understand how consumers evaluate product risk informa-
tion. Unfortunately, research on this topic has yielded
inconsistent findings. Some studies suggest that information
on product risks lowers consumers’ product evaluations
(e.g., Morris, Mazis, and Brinberg 1989; see also Goetzl
2001); however, others suggest that consumers frequently
ignore product risk information (e.g., Menon et al. 2003a),
and still others suggest that product risk information can
actually enhance consumers’ product evaluations (e.g.,
Goetzl 2000; Rodale Publications 1999).
In an effort to explain these contradictory findings, the
current study proposes a potential contingency variable that
may moderate the effect of product risk information on con-
sumers’ product evaluations: message framing. Any promo-
tional message can stress either the potential gains from
adopting a behavior or the potential losses from not adopt-
ing it. For example, a loss-framed advertisement promoting
flu vaccinations would stress the potential health costs of
not getting vaccinated (e.g., getting influenza), whereas a
gain-framed advertisement would stress the protective ben-
efits of getting vaccinated (e.g., avoiding influenza).
Although these two messages might contain the same
essential information, research suggests that they elicit dif-
ferent consumer responses (for a review of framing
research, see Levin, Schneider, and Gaeth 1998). Relevant
to the current study, there are theoretical reasons to believe
that message framing may moderate how consumers
respond to product risk.
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Function/risk theory (e.g., Meyerowitz and Chaiken
1987; Rothman and Salovey 1997) draws on Kahneman and
Tversky’s (1979) prospect theory to suggest that negatively
framed messages increase consumers’ willingness to use
high-risk products (particularly those with a problem detec-
tion function), whereas positively framed messages increase
the attractiveness of low-risk products. In contrast, other
theories (e.g., Adaval 2001; Isen 2000; Yuen and Lee 2003)
seem to suggest the opposite, positing that consumers
exposed to positive, upbeat stimuli should be more willing
to tolerate certain types of product risks, whereas those
exposed to negative stimuli should exhibit greater aversion
to such risks.
This article examines these theories and discusses their
(sometimes conflicting) implications for understanding how
consumers evaluate product risk. Specifically, we address
three central research questions:
1. How do consumers assess product risk? Specifically, how
are product risk perceptions influenced by both explicit
product risk disclosures and information on product func-
tion (e.g., problem prevention versus problem detection).
2. How do consumers weigh perceived product risks in form-
ing overall product evaluations?
3. How are the weights given to product risks influenced by
message framing?
In the following sections, we discuss previous research and
theory relevant to these questions. Then, we report the
results of two experiments that examine these issues empir-
ically. Finally, we discuss the implications of our findings
and provide directions for further research.
Effects of Product Function on
Perceived Product Risk
Several researchers have suggested that consumers perceive
detection products as inherently risky. Meyerowitz and
Chaiken (1987) first introduced the function/risk hypothesis
in the context of breast self-examination (BSE). They noted
(p. 89), “In the short run, BSE is a risky behavior.... [It]
requires that a woman risk aversive consequences in the
present (e.g., finding a lump, experiencing anxiety) in hopes
of enhancing future outcomes.... Of course, in the long run,
not performing BSE clearly entails risks (e.g., failing to
detect a malignancy). However, because of their temporal
remoteness, such longer-term considerations may be less
salient than short-term considerations.” More recently,
Rothman and Salovey (1997) reiterated the link between
product function and perceived risk, stating that detection
products are considered inherently risky because “one runs
the risk of receiving significant, unpleasant information” (p.
5), whereas prevention products (e.g., sunscreen, vaccines)
are considered low risk because their “salient function ... is
to provide a relatively certain, desirable outcome” (p. 11).
The hypothesized link between product function and
perceived risk is argued persuasively in these articles and
has gained widespread currency among persuasion
researchers and practitioners (as we discuss subsequently).
However, closer examination reveals problems with this
hypothesis. First, proponents of function/risk theory suggest
that consumers view adopting detection behaviors as more
risky than not adopting them. However, as Levin, Schnei-
der, and Gaeth (1998) note, this assumes that consumers
ignore the long-term risks of not being screened (e.g.,
allowing a tumor to grow) and focus solely on short-term
risks. The finding that consumer disease anxiety tends to
increase screening behavior, not decrease it (McCaul et al.
1996), suggests that many consumers adopt a longer-term
perspective on detection behaviors.
Second, although some detection products have short-
term risks, so do many prevention products. Many people
avoid flu shots for fear of pain and side effects (Centers for
Disease Control and Prevention 1995); many women do not
push condom use for fear of partners’ reactions (Darroch
and Frost 1999). If consumers focused only on short-term
outcomes, they would view these preventive products as
risky.
Finally, there is little empirical evidence that risk per-
ceptions vary with product function. Several studies have
examined consumer response to products differing in func-
tion (e.g., Rothman et al. 1999; Rothman et al. 1993), but
none has shown that detection and prevention products dif-
fer in perceived risk.
Effects of Message Framing on
Consumer Response to Product
Risk
Another tenet of function/risk theory is that loss-framed
messages make consumers more likely to adopt high-risk
(e.g., detection) products, whereas gain-framed messages
increase the attractiveness of low-risk (e.g., prevention)
products. In reviewing previous framing studies, Rothman
and Salovey (1997) note that loss-framed messages seem to
be more persuasive in studies involving detection products,
whereas gain-framed messages seem to be more effective in
studies involving prevention products. To explain this
apparent difference, they note that prospect theory (Tversky
and Kahneman 1981) suggests that consumers prefer riskier
options when outcomes are framed as losses but prefer low-
risk options when outcomes are framed as gains (see also
Meyerowitz and Chaiken 1987, p. 501). Thus, they con-
clude that loss-framed messages will persuade people to
adopt detection (and other risky) products and that gain-
framed messages will persuade people to adopt prevention
(and other low-risk) products.
This hypothesis is compelling and, if valid, has impor-
tant marketing implications. It suggests that marketers pro-
moting prevention products (e.g., vaccinations) should use
gain-framed messages, whereas those promoting detection
behaviors (e.g., HIV testing) should use loss-framed mes-
sages. More broadly, it suggests that any product that con-
sumers perceive as risky is most effectively promoted with
loss-framed messages.
This theory has become increasingly influential among
both persuasion researchers and practitioners. Rothman and
Salovey’s (1997) article has been cited more than 100 times
(Thomson 2004), and the function/risk hypothesis is
becoming established doctrine among social marketers (see,
e.g., Arkes 2004; Ferguson et al. 2003). However, despite
increasing acceptance of this hypothesis, there are unre-
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solved questions about both its empirical support and its
theoretical foundation. First, although some studies find
loss framing more persuasive in promoting detection and
find gain framing more persuasive in promoting prevention,
other studies find just the opposite. For example, Robberson
and Rogers (1988), Homer and Yoon (1992), and Blanton
and colleagues (2001) all find loss framing more effective
in promoting prevention behaviors (exercise, mouthwash,
and condoms, respectively).
Second, in most studies cited to support function/risk
theory, function is confounded with other product traits. For
example, mammograms and sunscreen differ not only in
function but also in the problems they address, cost, dis-
comfort, and so forth. If framing effects differ between
these two products, which of these product traits accounts
for the difference? The only study to manipulate product
function while holding other product attributes constant
(Rothman et al. 1999, Study 1) does not find the predicted
two-way interaction between function and framing.
Third, the function/risk hypothesis has theoretical prob-
lems. Assume that consumers view detection as high risk
and prevention as low risk. Does the function/risk hypothe-
sis then follow logically from prospect theory? Indeed,
Tversky and Kahneman (1981) find that when outcomes
were framed as losses, consumers preferred the riskier of
two options. However, Tversky and Kahneman use “risk” to
mean increased variance of potential outcomes; therefore,
the riskier options in their experiments had both greater
upside potential and greater downside potential than the no-
risk (or certain) options. Given this definition of risk,
choosing a risky option seems more reasonable. Prospect
theory posits that people abhor a certain loss (e.g., with
Option A, there is a definite loss of $2,000) and thus are so
attracted to the upside potential of complete loss avoidance
(e.g., Option B provides a 50% chance to lose nothing) that
they are willing to tolerate the downside potential of even
greater losses (e.g., a 50% chance of losing $4,000).
In contrast, when function/risk theorists argue that
detection behaviors are risky, they use risk to mean an
increased possibility of negative outcomes (or what Tversky
and Kahneman call downside risk). Consumers who adopt
detection behaviors are said to expose themselves to the
possibility of short-term psychological loss (e.g., learning
they have cancer), whereas nonadopters completely avoid
such short-term loss potential. Thus, if the function/risk
theorists’ assumption that consumers focus solely on short-
term outcomes is accepted, adoption of a detection behavior
must be viewed as a kind of psychological Russian roulette,
in which consumers actually seek potential short-term
losses, with little thought to detection’s long-term benefits.
Such loss-seeking behavior is antithetical to the tenets of
prospect theory.
Alternative Theories of Framing and
Risk: Valence Congruency and Risk
Discrimination
Whereas function/risk theory posits that consumers exposed
to loss-framed messages actually seek short-term product
risks, we propose two alternative theoretical formulations
that suggest essentially the opposite: Loss-framed messages
induce risk aversion, whereas gain-framed messages
increase consumers’ tolerance of at least some types of
product risk. These two theories (valence congruency and
risk discrimination) both rest on two key findings.
First, there is evidence that message framing influences
consumers’ moods, particularly positive moods. In depth
interviews, Cox and Cox’s (2001) respondents reported
positive, optimistic feelings after exposure to gain-framed
messages that promoted mammography and less positive
moods after exposure to equivalent loss-framed messages.
Similarly, Meyerowitz and Chaiken (1987, p. 506) find that
gain-framed respondents were significantly more likely to
report feeling “reassured.” Thorsteinson and Highhouse
(2003) find that respondents exposed to gain-framed want
ads reported more positive scores on the Associative
Valence index (e.g., “hopeful,” “confident,” “optimistic”)
than those exposed to loss-framed messages. Perhaps this
finding is not too surprising, because gain-framed messages
depict happy endings (in which people do the right thing
and, consequently, win money, live long lives, and so forth)
and loss-framed messages depict unhappy endings (in
which people miss opportunities, lose money, get sick, and
so forth.) However, the potential emotional impact of mes-
sage framing has received remarkably little attention in the
framing literature, which has tended to adopt the cognitive
emphasis of behavioral decision theory (cf. Loewenstein et
al. 2001).
Second, considerable research suggests that consumers
exposed to affectively positive stimuli are more willing to
tolerate at least some product risk to take advantage of
product benefits. However, this literature contains two
schools of thought that disagree on whether positive moods
increase consumer tolerance of all kinds of risk or simply
make consumers more likely to disregard relatively small
“low-stakes” product risks.
The valence congruency theory suggests that consumers
in positive moods tend to give less decisional weight to all
negative product information (e.g., product risks) than con-
sumers in negative moods. This hypothesis is often
explained in terms of information priming, in which prior
exposure to affectively negative material is theorized to
increase the accessibility of potential negative conse-
quences (i.e., risk) in memory, whereas exposure to affec-
tively positive material decreases accessibility of potential
negative consequences. For example, Pietromonaco and
Rook (1987, p. 400) theorize that negative affect “may
influence the perceived likelihood of unpleasant events
because it increases the accessibility of previous similar
experiences and thus facilitates imagining other potential
negative outcomes.”
Several studies have produced results that appear to be
consistent with the valence congruency hypothesis, such that
respondents in positive moods exhibit greater risk tolerance
(e.g., Deldin and Levin 1986; Pietromonaco and Rook 1987;
Yuen and Lee 2003). However, as Isen (2000) observes,
many of these studies presented behavioral risks that were
relatively minor (e.g., temporary or minor embarrassment, a
small or hypothetical bet). In contrast, in tasks involving
high stakes, respondents in positive moods often exhibit
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considerable caution regarding potential risks (see, e.g., Isen
and Geva 1987). Therefore, Isen (2000) and Isen and Geva
(1987) propose a more complex theory of affect and risk
taking, which can be labeled risk discrimination theory.
According to this theory, consumers in positive moods are
better able to discriminate between important, high-stakes
risks and more minor, low-stakes risks. Therefore, con-
sumers in positive moods are more likely to disregard rela-
tively trivial risks than are consumers in negative moods, but
they may be reluctant to take large risks. In a sense, con-
sumers in good moods are hypothesized to weigh risks more
appropriately in proportion to their relative importance.
Several studies appear to support this theory (for a
review, see Isen 2000). For example, in an experiment
involving gambling behavior, Isen and Geva (1987, p. 145)
find that “when stakes were high,... positive affect subjects
were more cautious, whereas when stakes were low, posi-
tive affect subjects were more prone to take risks.” Several
writers have suggested that this phenomenon is part of a
broader pattern, in which respondents in positive moods are
simply better decision makers (i.e., they are better able to
weigh and integrate information rationally and to distin-
guish the relevant from the irrelevant). For example, Isen
(2000, p. 423) states that “positive affect promotes effective
thinking about even negative material, if doing so is useful
and necessary, even though it also leads people to sidestep
unnecessary consideration of undesirable material. This is
yet another way in which positive affect promotes flexible
problem solving.”
In contrast, negative affect is hypothesized to inhibit
appropriate weighing of costs and benefits. In the words of
Leith and Baumeister (1996, p. 1251), “negative affect
apparently inhibits people from considering the affective
consequences of possible actions ... [and may induce] poor
choices in situations in which there is a long-term [versus]
short-term tradeoff.”
Hypotheses
Our first two hypotheses challenge two central tenets of
function/risk theory: (1) that consumers perceive detection
products as inherently riskier than prevention products and
(2) that product function (detection versus prevention) mod-
erates the persuasive effects of message framing. As we dis-
cussed previously, the theoretical and empirical bases for
these tenets appear questionable. Therefore, our first two
hypotheses are null or “theory refutation” hypotheses:
H1: Product function per se does not influence perceived prod-
uct risk; that is, consumers do not perceive disease detec-
tion products as inherently riskier than prevention prod-
ucts that have the same product form, usage experience,
and side effects.
H2: Product function per se does not moderate the persuasive
effects of message framing; that is, message-framing
effects do not differ between detection products and pre-
vention products that have the same product form, usage
experience, and side effects.
The next two hypotheses are based on our discussion of
the valence congruency and risk discrimination theories. As
we noted previously, both theories predict that message
framing moderates how consumers respond to potential
product risks but not in the manner predicted by function/
risk theory. Consistent with both the valence congruency
and the risk discrimination theories, but contrary to
function/risk theory, we hypothesize the following:
H3: Consumers exposed to gain-framed messages exhibit less
aversion to temporary product risks (i.e., those involving
the potential for temporary negative effects) than con-
sumers exposed to loss-framed messages. Consumers
exposed to gain-framed messages respond less negatively
to a disclosure of such temporary product risk and give
less weight to perceived product risk in forming overall
product evaluations than consumers exposed to loss-
framed messages.
However, as we noted previously, the valence congru-
ency and risk discrimination theories diverge on how fram-
ing influences the relative weight that consumers give to
minor product risks (e.g., the risk that product use may
cause temporary unpleasant effects) versus more serious
product risks (e.g., the risk that product use may cause per-
manent harm). Valence congruency theory suggests that
exposure to positive, gain-framed information should
decrease the weight given to all product risks, large and
small. In contrast, risk discrimination theory suggests that
exposure to gain-framed messages should enhance con-
sumers’ ability to assess the emotional impact of different
types of risks accurately and therefore cause them to give
greater weight to serious risks than to smaller risks. Because
risk discrimination has been better able to explain the range
of previous empirical results, we base H4 on this theory:
H4: Message framing influences the relative weight that con-
sumers give to product risks involving temporary versus
permanent adverse consequences. Consumers exposed to
gain-framed messages give significantly more decisional
weight to permanent product risks than to temporary prod-
uct risks. In contrast, consumers exposed to loss-framed
messages respond equally negatively to both types of
product risk.
Study 1
Product Context and Participants
We examined our first three hypotheses in the context of
skin cancer detection and prevention products. Skin cancer
is the most common and one of the most rapidly growing
forms of cancer. In 2002, there were 54,200 cases of skin
cancer in the United States alone, and 7600 Americans died
from the disease (American Cancer Society 2004).
A primary target audience for promoting skin cancer
prevention and detection behaviors is young adults, a group
that is especially likely to engage in behaviors (e.g., sun
bathing, other outdoor recreational activities) that increase
lifetime skin cancer risk. Therefore, the participants for this
study were young adults whom we recruited from under-
graduate business classes at a large urban university in the
midwestern United States.
Experimental Design and Stimuli
In designing this experiment, we attempted to minimize
some of the methodological problems that have plagued
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prior research on product function and risk. Specifically, in
most prior studies, product function has been confounded
with other product differences, such as cost, discomfort,
frequency of use, and so forth. To address this problem, we
developed gain- and loss-framed print advertisements for
two product concepts that differ in function (detection ver-
sus prevention) but address the same underlying problem
(skin cancer) and involve equivalent usage experience.
Pretest
Purpose. In the pretest, we attempted to test partici-
pants’ comprehension of the message-framing and product
function message components and to confirm that message
framing serves as a mood manipulation. Perdue and Sum-
mers (1986) suggest that such manipulation checks are best
conducted in a separate pretest rather than included in the
“main” experiment that examines the dependent variables
(e.g., brand attitudes, intentions). They note (p. 319) that
“including these checks in the main experiment can present
problems independent of whether they come before or after
the dependent variable measures.” Manipulation checks
placed before the dependent measures may bias the latter
(e.g., by creating demand effects), whereas manipulation
checks placed after the dependent measures may fail to
detect stimulus effects that are inherently transient, such as
mood inductions (see, e.g., Vastfjall 2002). Therefore, we
conducted a separate pretest to test the effects of our
manipulations.
Method. We recruited 70 participants (37 male and 33
female) from undergraduate business classes. Each partici-
pant was assigned randomly to one of four experimental
advertisements, which varied in behavioral function (pre-
vention versus detection) and message framing (gain framed
versus loss framed). Each advertisement had the same pic-
ture (a stylized picture of the sun) and headline (“Important
News for Young Adults About Skin Cancer”). The body of
each advertisement contained three components: (1) basic
information about skin cancer (drawn from the American
Cancer Society Web site), which was identical for all
experimental groups; (2) one of two skin cancer protection
product concepts that differed in function (prevention versus
detection) but had the same product form and usage experi-
ence (both were lotions applied in a doctor’s office that
were described as “highly effective and very safe”); and (3)
an advocacy message that urged consumers to adopt the
product, which was either gain framed or loss framed.
After message exposure, pretest participants responded
to manipulation checks for perceived product function,
message framing, and mood. As a framing manipulation
check, respondents used seven-point Likert scales to report
whether they believed the message “emphasized the benefits
of using the product” or “emphasized the costs of not using
the product.” As a product function manipulation check,
participants reported agreement that “the lotion helps pre-
vent skin cancer” and “the lotion helps detect skin cancer.”
We measured postexposure mood using scales we
adapted from the work of Howard, Gengler, and Jain (1995)
and Meyerowitz and Chaiken (1987). On seven-point Likert
scales, each respondent reported the degree to which 14
adjectives (e.g., assured, cheerful, afraid, happy, troubled)
described his or her mood state. These responses were
entered into a principal components analysis with a Vari-
max rotation. After the elimination of some items because
of high cross-loadings, the final analysis extracted two
interpretable factors with eigenvalues greater than one,
which together explained 75% of the variance in the indi-
vidual items. The first factor captured participants’ hopeful-
ness or optimism; items loading on this factor were “hope-
ful,” “cheerful,” “assured,” and “happy.” The second factor
tapped into participants’ anxiety mood state; items loading
on this factor were “afraid,” “disturbed,” “troubled,” and
“worried.” All loadings were greater than .75, and all cross-
loadings were less than .15. Next, we constructed two
summed scales based on the items loading on these two fac-
tors. The hopefulness mood scale had a coefficient alpha
value of .84, and the anxiety mood scale had an alpha value
of .92. These two summed scales were not significantly cor-
related with each other, suggesting that hopefulness and
anxiety represent two distinct emotional dimensions, not
simply different ends of the same continuum.
Pretest results. When asked whether the message com-
municated the “benefits of product use,” participants
exposed to the gain-framed version were slightly more
likely to agree (X = 5.58) than those exposed to the loss-
framed version (X = 5.07); however, this difference did not
reach statistical significance (F = 2.69, p = .11). However,
when asked more specifically if the advertisement “empha-
sized the costs of not using the product,” participants in the
loss-framed condition were much more likely to agree (X =
5.27) than those in the gain-framed condition (X = 4.06; F =
11.9, p < .001). This latter finding indicates that the partici-
pants comprehended the framing of the messages.
Participants exposed to the prevention product concept
were much more likely to agree that the “lotion helps pre-
vent skin cancer” (X = 4.90) than those exposed to the
detection product concept (X = 3.11; F = 15.5, p < .001).
Likewise, participants exposed to the detection product
were much more likely to agree that the “lotion helps detect
skin cancer” (X = 5.97) than those exposed to the preven-
tion product (X = 3.04; F = 60.0, p < .001).
The pretest also confirmed that consumers experience
more positive moods after exposure to gain-framed mes-
sages than after exposure to loss-framed messages. Partici-
pants exposed to the gain-framed message reported signifi-
cantly higher levels of hopefulness (X = 3.88) than those
exposed to the loss-framed message (X = 2.98; F = 8.9, p =
.004). There was no significant difference in the reported
anxiety level of the two message-framing groups.
Main Experiment
Purpose of study. This experiment has three main pur-
poses. First, it tests H1, that contrary to function/risk theory,
disease detection products are not perceived as inherently
riskier than prevention products involving the same disease,
product form, and usage experience. Second, it tests H2,
that the persuasive effects of message framing do not vary
with product function. As we noted previously, function/
risk theory posits that loss-framed messages are most per-
suasive when advocating detection behaviors, whereas gain-
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framed messages are most persuasive when advocating pre-
vention behaviors. However, we argue that the theoretical
rationale for this hypothesis (ostensibly based on prospect
theory) is problematic and that the empirical evidence in
support of it is inconclusive (in part because in most stud-
ies, product function is confounded with other product dif-
ferences). Thus, this experiment attempts to provide a rigor-
ous test of the proposed interaction between function and
framing, independently manipulating message frame and
product function while holding other variables constant.
Third, the experiment examines H3, that consumers exposed
to gain-framed messages exhibit less aversion to temporary
product risks (i.e., those involving the potential for tempo-
rary negative effects) than consumers exposed to loss-
framed messages. To test this hypothesis, the experiment
manipulates product risk independent of product function.
Sample. We recruited 282 young adults from undergrad-
uate business classes at a large urban university in the Mid-
west. The sample was 41% female and had a median age of
22.5 years.
Design and stimuli. The experiment used a 2 × 2 × 2
between-subjects factorial experimental design. The factors
were message framing (gain framed versus loss framed),
product function (prevention versus detection product), and
product risk disclosure (presence versus absence of tempo-
rary side-effect risk). The manipulation of framing and
function were identical to the pretest. We varied product
risk disclosure by having the messages state either that the
lotion is “very safe” or that the lotion was “generally safe”
but in some patients could cause a temporary skin rash that
could last for several weeks. Because a product’s side-effect
profile (i.e., its potential for unintended physical discomfort
or harm to the product user) is conceptually distinct from its
function (its core purpose or stated customer benefit), this
manipulation enabled us to vary product risk independent of
product function.
We randomly assigned participants to one of eight
experimental advertisements. Each advertisement had the
same picture, headline, and basic information about skin
cancer as described in the pretest. These were followed by
two paragraphs, which contained the experimental manipu-
lations: (1) a paragraph that described one of four skin can-
cer protection product concepts (a low-risk prevention prod-
uct, a risky prevention product, a low-risk detection
product, or a risky detection product) and (2) a message,
which was either gain framed or loss framed, that urged
consumers to adopt the product (examples of the experi-
mental messages appear in the Appendix). Test booklets
containing the eight experimental messages were randomly
assigned to participants within each classroom.
Measures. We assessed perceived product risk by hav-
ing participants report their agreement on seven-point Lik-
ert scales with a series of statements regarding the potential
negative consequences of product use: “Using this lotion is
risky,” “This lotion can lead to bad results,” “Using this
lotion would make me feel anxious,” and “Using this lotion
would cause me to worry.” We combined participants’
scores on these four items to form a mean scale with a coef-
ficient alpha of .77. We assessed overall product evaluation
by having participants report their agreement on seven-
point Likert scales with the following statements: “Overall,
I think this lotion is a very good product,” “People who use
this lotion will be safer than those who don’t,” “I would
rather use this lotion than any currently available alterna-
tive,” and “Using this lotion would be important to me.” We
combined these items to form a mean scale with a coeffi-
cient alpha of .76. We assessed behavioral intentions by
having participants report on seven-point bipolar scales,
anchored by “very likely” and “very unlikely,” their inten-
tion to engage in three behaviors involving the target prod-
uct: asking their doctor about the product, purchasing the
product, and using the product. We combined these to form
a mean scale with a coefficient alpha of .90. Finally, partici-
pants provided demographic information (e.g., gender, age,
education) and reported on their previous skin cancer pre-
vention behaviors (e.g., use of sunscreen) and risk factors
(e.g., sun exposure, severe sunburns, family history).
Results. We examined perceived product risk with an
analysis of variance (ANOVA), in which perceived product
risk was the dependent variable and framing, product risk
disclosure, and function were dichotomous factors. As we
predicted in H1, there was no evidence that participants per-
ceived detection products as inherently riskier than preven-
tion products. Product function had no impact on perceived
product risk (F = .24, p = .63). The mean perceived risk of
the detection product (X = 3.60) was virtually identical to
that of the prevention product (X = 3.53). Thus, we found
support for H1.
However, there was a strong main effect of the side-
effect manipulation on perceived product risk (F = 24.9, p <
.001). Participants in the side-effects disclosure condition
perceived significantly greater product risk (X = 3.9) than
those in the no-side-effects condition (X = 3.2).
Message framing did not have significant main or inter-
active effects on participants’ perceptions of product risk
level. However, as we discuss subsequently, message fram-
ing altered the weight that participants gave to such risk
perceptions in forming overall product evaluations.
Overall product evaluations. Next, we conducted an
ANOVA that evaluated the effect of message framing, prod-
uct function, and product risk disclosure on participants’
overall product evaluations. Consistent with H2, there was
no interaction between message framing and product func-
tion (F = .03, p = .87).
However, framing moderated the impact of the product
risk disclosure on participants’ overall product evaluations
(see Figure 1). As we predicted in H3, there was a statisti-
cally significant interaction between message frame and
product risk disclosure (F = 11.19, p = .001). To understand
this significant interaction better, we analyzed the simple
effects of the product risk disclosure in each of the two fram-
ing conditions (see, e.g., Keppel 1982, pp. 214–19). This
analysis revealed that consumers exposed to loss-framed
messages rated the risky (temporary side effects) product
significantly more negatively (X = 4.08) than the low-risk
(no side effects) product (X = 4.77; F = 13.17, p < .001). In
contrast, in the gain-framed condition, consumers’ product
evaluations did not differ between the risky product (X =
4.40) and the low-risk product (X = 4.20; F = 1.20, p = .27).
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FIGURE 1
Study 1: Effect of Stated Product Risk on Overall
Product Evaluations: Gain-Framed Versus Loss-
Framed Conditions
To examine further how message framing affects con-
sumers’ sensitivity to product risk, we examined whether
the correlation between perceived product risk and overall
product evaluations varied significantly between the gain-
and loss-framed conditions (for a similar analysis, see
Pietromonaco and Rook 1987). This analysis revealed that
among participants exposed to loss-framed messages, over-
all product evaluations were negatively correlated with per-
ceived product risk (r = –.31, p < .001). However, among
participants exposed to gain-framed messages, overall prod-
uct evaluations were not significantly correlated with per-
ceived product risk (r = –.07, p = .38). A Fisher r-to-z trans-
formation (Kleinbaum and Kupper 1978, pp. 106–107)
confirmed that the correlation between perceived product
risk and overall product evaluation was significantly differ-
ent across the two framing conditions (z = 2.04, p < .05).
This analysis provides further evidence that participants
exposed to gain-framed messages gave less evaluative
weight to the product’s risks than did those exposed to loss-
framed messages.
Behavioral intention. Next, we conducted an ANOVA in
which behavioral intention was the dependent variable and
message framing, product function, and product risk disclo-
sure were dichotomous factors. As we predicted in H2, there
was no interaction between product function and message
framing (F = 1.92, p = .17). However, there was a signifi-
cant interaction between product risk disclosure and mes-
sage framing (F = 4.80, p < .05). Tests of simple effects
revealed that participants in the loss-framed condition
reported significantly greater intention to adopt the low-risk
product (X = 4.50) than the risky product (X = 3.75; F =
6.58, p = .01). Among participants in the gain-framed con-
dition, there was no significant difference in behavioral
intention toward the risky (X = 4.17) and low-risk (X =
4.03) products (F = .25, p = .62) (see Figure 2).
Next, we conducted mediation analysis to determine
whether within the loss-framed condition, the effect of risk
disclosure on behavioral intention was mediated by overall
product evaluation. We used Baron and Kenny’s (1986)
mediation test method, estimating a series of regression
models and testing the significance of the (unstandardized)
regression coefficients. First, a bivariate regression model
confirmed that risk disclosure had a significant impact on
the overall product evaluation (B = –.693; t = –3.68, p <
.001). Second, a bivariate regression model confirmed that
risk disclosure had a significant effect on behavioral inten-
tion (B = –.745; t = –2.5, p = .01). Third, we regressed
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Study 1: Effect of Stated Product Risk on
Behavioral Intention: Gain-Framed Versus 
Loss-Framed Conditions
Product
Evaluation
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behavioral intention simultaneously on both product risk
disclosure and product evaluation. This analysis revealed
that the proposed mediator (product evaluation) had a sig-
nificant influence on behavioral intention (B = .986; t =
9.35, p < .001), whereas the effect of the independent varia-
ble (risk disclosure) became nonsignificant (B = –.06; t =
–.25, p = .80) when the mediator was controlled. Thus, our
analysis meets all four of Baron and Kenny’s criteria to
establish that the effect of risk disclosure on behavioral
intention is completely mediated by product evaluation.
Finally, Sobel’s (1982) test confirmed the statistical signifi-
cance of the indirect effect of risk disclosure on intention
mediated by product evaluation (z = –3.43, p < .001).
Discussion of Study 1
Study 1 shows that consumers exposed to loss-framed mes-
sages exhibit a greater aversion to a temporary product risk
(i.e., involving potential temporary negative outcomes) than
do consumers exposed to gain-framed messages (who gave
essentially zero decisional weight to such product risks).
This finding is contrary to function/risk theory, which states
that loss-framed messages induce risk-seeking behavior, but
is consistent with both valence congruency theory and risk
discrimination theory. However, Study 1 does not indicate
whether gain-framed messages increase consumers’ toler-
ance for all risks (as would be predicted by valence congru-
ency theory) or simply minor, temporary risks (as predicted
by risk discrimination theory). Not only is this difference
theoretically interesting, but it may also have important
marketing and public policy implications. If gain-framed
messages cause consumers to disregard all product risk
information, such messages might (intentionally or uninten-
tionally) result in imprudent decisions about products
entailing serious risks (which, as we noted previously, are
increasingly being marketed directly to consumers). Con-
versely, if gain-framed messages merely cause consumers
to disregard minor, temporary risks in the pursuit of long-
term health benefits, such messages might actually help
consumers make more rational decisions to protect their
long-term health.
Given the importance of this issue, we address it in a
second study, which examines the impact of message fram-
ing on consumers’ responses to two kinds of product risk:
the risk that product use may cause temporary unpleasant
effects versus the risk that product use may cause perma-
nent serious harm.
Study 2
Purpose
Study 2 serves two main purposes. First, it enables us to
replicate the test of H3 (that consumers exposed to gain-
framed messages give less weight to temporary product
risks than consumers exposed to loss-framed messages) in a
completely different product context. Second, it enables us
to test H4 (that message framing influences the relative
weight that consumers give to product risks involving tem-
porary versus permanent adverse consequences).
Product Context
This study examines the effects of message framing and
perceived product risk in the context of hepatitis B virus
(HBV) vaccination adoption. Hepatitis B is a serious viral
infection of the liver, which can lead to chronic hepatitis
and, in some cases, death. It is transmitted in a manner
similar to HIV (e.g., through unprotected sex, sharing of
needles). However, the risk of HBV infection (unlike HIV)
can be greatly reduced by the use of an effective vaccine,
ideally administered in a series of three doses (Krugman
and Stevens 1994). Unfortunately, many sexually active
adults decline the vaccine, even when it is offered for free
(Weinstock et al. 1995). Therefore, increased adoption of
the HBV vaccine is a major social marketing goal in both
the United States and other countries.
Overview of Study Design
The study is a randomized experiment. We recruited volun-
teers from the patient populations at three public sexually
transmitted disease (STD) clinics located in two large mid-
western cities, and we randomly assigned them to treatment
conditions that included either gain-framed or loss-framed
messages advocating the HBV vaccination. Because HBV
is an STD, clinic patrons are a prime target audience for
promoting the HBV vaccination.
The randomization was executed and the experimental
messages and questionnaire were administered by means of
an audio computer-assisted self-interview (A-CASI) tool,
which is an effective tool particularly for addressing sensi-
tive topics such as STDs (see, e.g., Turner et al. 1998.)
Before participants were exposed to the experimental
messages, they were asked a series of questions about their
perceptions of two distinct components of product risk: the
temporary product risks associated with getting shots (e.g.,
pain) and the more permanent risks associated with the
HBV vaccine (e.g., the possibility that the vaccine might
harm their health). Then, following exposure to either gain-
framed or loss-framed messages, participants were asked
about their behavioral intentions regarding the product.
Participants and Procedure
A total of 213 adult (age 18 years and older) participants
were recruited by a trained project manager from the patient
populations of the three STD clinics over a period of several
months. Participants were screened to ensure that they had
no prior self-reported history of HBV infection or vaccina-
tion and that they were fluent in English. The sample was
60% male and had a median age of 27.5 years. Approxi-
mately 85% of the sample had at least a high school
diploma or equivalent.
After screening for study eligibility, each participant
signed a written informed consent form and then was
directed to a private area with a touch-screen notebook
computer with headphones. The project manager familiar-
ized the participant in the use of the A-CASI equipment and
allowed the participant to complete the interviewing process
in private. The project manager had no awareness of either
the message treatment group to which participants were
randomly assigned or participants’ questionnaire responses.
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Before the framing intervention, participants completed
a series of questions about demographics, prior behaviors
that might affect susceptibility to HBV infection (e.g., sex-
ual behaviors), and perceptions of both the temporary risks
of HBV vaccination (e.g., injection pain) and the risks of
more permanent negative outcomes (e.g., the possibility
that the vaccine itself might cause HBV infection; we dis-
cuss these measures in greater depth subsequently). Next,
each participant was randomly assigned a message that
advocated the adoption of the HBV vaccination that was
either gain framed or loss framed. After exposure to the
message, participants reported their behavioral intentions.
Stimuli
The message opened with a gain- (loss-) framed general
statement about the consequences of getting (or not getting)
the vaccination, followed by two gain- (loss-) framed anec-
dotes that illustrated these consequences. To increase the
perceived personal relevance of the messages, the A-CASI
program automatically matched the gender (i.e., names) of
the people described in the two anecdotes to the partici-
pant’s gender; otherwise, the male and female messages
were identical. The male version of the message is as fol-
lows (the gain-framed version appears in normal text, and
the loss-framed language appears in bold):
People who get (don’t get) the hepatitis B shot are gain-
ing (losing) a chance to protect themselves and the ones
they love.
Michael felt very healthy and didn’t believe he would be
infected by the Hepatitis B virus, [b]ut he followed (so he
didn’t follow) the advice of the American Medical Asso-
ciation and got (didn’t get) 3 hepatitis B vaccine shots
over 6 months. Because of this, he is (not) protected
against hepatitis B infection. Now he is much less (much
more) likely to get sick or die from serious liver disease,
and he can look forward to (may miss out on) a long and
healthy life, watching his child grow up.
James decided he needed (didn’t need) to protect himself
and got (didn’t get) the hepatitis B vaccine. As a result,
he did not get infected (got infected) after having sex with
an infected partner. Because James did not get infected
(got infected) with the hepatitis B virus, he did not pass it
on (passed it on) to his new partner. So his new partner
did not get sick (got sick) with hepatitis B, and now they
have gained (lost) a chance for a healthy future together.
We checked this message-framing manipulation in a
pretest, in which 38 young adults (average age of 29 years)
were randomly assigned either the gain- or the loss-framed
message and then responded on Likert scales (7 = “strongly
agree,” 1 = “strongly disagree”) to two statements: “This
message focuses on the benefits of getting the hepatitis B
shot,” and “This message focuses on the negative conse-
quences of not getting the hepatitis B shot.” As we
expected, participants assigned to the gain-framed message
condition (X = 5.23) were more likely than the participants
in the loss-framed message condition (X = 3.25) to agree
that the message focused on the benefits of compliance (t =
4.29, p < .001). Conversely, participants in the loss-framed
message condition (X = 6.25) were more likely than partici-
pants in the gain-framed message condition (X = 4.23) to
agree that the message stressed the negative consequences
of noncompliance (t = 3.57, p = .001).
Constructs and Measures
Perceived product risk. Consumers’ decisions to get
vaccinated are sometimes influenced by their perceptions of
two fairly distinct types of product risk. First, there is the
perceived risk of temporary pain or discomfort from the
needle or injection itself, which sometimes deters con-
sumers from getting vaccinations and other medical proce-
dures involving the use of needles (see, e.g., French and
Painter 1994; Zimet et al. 2004). Second, there is the per-
ceived risk of more permanent harm caused by the specific
vaccine (e.g., the perceived risk that the vaccine will trans-
mit the disease in question or otherwise cause serious ill-
ness or long-term disability; see, e.g., Ball, Evans, and
Bostrom 1998).
Before exposure to the framed messages, participants
completed a series of measures that assessed these two
dimensions of product risk. To assess the perceived risk of
shots/needles, participants reported their agreement (on
five-point Likert scales) with four items (e.g., “Shots are
very painful,” “Needles don’t bother me at all [reversed]”),
which we combined to form a mean scale with a coefficient
alpha of .80. To assess perceived risk of the HBV vaccine,
participants reported their agreement with six items (e.g.,
“The vaccine shots for hepatitis can make people very sick,”
“You can get infected with hepatitis from the hepatitis vac-
cine shots”), which we combined to form a mean scale with
an alpha of .78. As we previously discussed, these two
dimensions of perceived product risk appear to be distinct.
The two mean scales were not significantly correlated (r =
.098). Furthermore, when all ten items are combined in a
factor analysis with an orthogonal rotation, the respective
sets of scale items load together on two distinct factors
(eigenvalues > 1) with factor loadings between .6 and .9 and
minimal cross-loadings (all < .08).
Behavioral intentions. We assessed participants’ inten-
tions regarding the HBV vaccination with three items: a
dichotomous yes/no question (“If you were offered the
hepatitis B vaccine for free at this clinic, would you get the
shot?”) and two five-point Likert scale items (“I would rec-
ommend that my partner get hepatitis vaccine shots,” and “I
would recommend that my friends or family members get
hepatitis vaccine shots”). These three items were highly
intercorrelated and loaded together on a single factor that
explained 78% of their combined variance. Therefore, the
three items were all converted to standardized scores (to
adjust for scaling differences) and then combined to form a
mean scale with a coefficient alpha of .87.
Results
We tested H3 to examine whether (as in Study 1) message
framing influences the decisional weight that consumers
give to temporary product risks. To address this issue, we
calculated the correlation between behavioral intention and
perceptions of temporary product risk (i.e., risk of short-term
injection discomfort), and then we examined whether this
correlation differed between the gain- and the loss-framed
conditions (see Pietromonaco and Rook 1987). As in Study
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1, this analysis revealed that among participants exposed to
loss-framed messages, overall product evaluations were
negatively correlated with perceived temporary product risk
(r = –.30, p < .01). However, among participants exposed to
gain-framed messages, overall product evaluations were not
significantly correlated with perceived temporary product
risk (r = –.01, p = .92). A Fisher r-to-z transformation
(Kleinbaum and Kupper 1978, pp. 106–107) confirmed that
the correlation between perceived temporary product risk
and overall product evaluation was significantly different
across the two framing conditions (z = 2.18, p < .05).
As an additional test of H3, we conducted an ANOVA to
examine how framing moderates consumer response to high
versus low levels of temporary and permanent product risk.
This analysis involved three steps. First, as we noted previ-
ously, a factor analysis of the perceived risk items produced
two orthogonal factors, one representing perceived tempo-
rary product risk (i.e., shot/needle pain) and the other repre-
senting perceived permanent product risk (i.e., serious ill-
ness caused by the vaccine). Second, we performed a
median split on each of these factor scores, which resulted
in two uncorrelated dichotomous factors: perceived tempo-
rary product risk (high versus low) and perceived permanent
product risk (high versus low). Third, we performed a 2 ×
2 × 2 ANOVA of behavioral intentions, in which message
framing (gain versus loss), temporary product risk (high
versus low), and permanent product risk (high versus low)
were dichotomous factors. This analysis showed significant,
negative main effects of both permanent product risk (F =
25.4, p < .001) and temporary product risk (F = 4.1, p < .05)
on behavioral intentions. However, consistent with H3, the
ANOVA also revealed a significant interaction between
framing and temporary product risk (F = 4.08, p < .05). As
we hypothesized, perceived temporary product risk had a
significant, negative effect on behavioral intentions among
loss-framed participants (F = 6.34, p = .01) but had no
impact among gain-framed participants (F = .09, p = .77).
Thus, both the HBV study and the skin cancer experi-
ment, though using different participant populations, set-
tings, and products, produced remarkably similar results: In
both studies, participants exposed to loss-framed messages
gave considerably more decisional weight to temporary dis-
comfort risk (either skin rash or shot pain) than participants
exposed to gain-framed messages. Indeed, gain-framed par-
ticipants in both studies gave essentially zero decisional
weight to such temporary product risks.
Next, we examined H4, that message framing influences
the relative weight that consumers give to temporary prod-
uct risks versus permanent product risks. As we hypothe-
sized, among participants in the loss-framed condition,
behavioral intentions were negatively correlated with both
perceived temporary product risks (r = –.30, p < .01) and
perceived permanent product risks (r = –.35, p < .01). To
assess the difference between these values, we calculated
Meng, Rosenthal, and Rubin’s (1992) z statistic. Note that
in testing H3, we used the Fisher r-to-z transformation,
which is most appropriate for comparing the same correla-
tion across two different samples. However, Meng, Rosen-
thal, and Rubin’s test is most appropriate for comparing the
magnitude of two different correlations (e.g., rtemprisk,intent
versus rpermrisk,intent) within the same sample (e.g., loss-
framed participants), in which each correlation is between a
common dependent variable (intention) and alternative pre-
dictor variables (temporary risk versus permanent risk).
Meng, Rosenthal, and Rubin’s test found no significant dif-
ference between rtemprisk,intent and rpermrisk,intent among loss-
framed participants (z = .38, p = .70), suggesting that loss-
framed participants give roughly equal weight to permanent
versus temporary risks in forming behavioral intentions.
Among gain-framed participants, behavioral intentions
were (as we reported previously) uncorrelated with per-
ceived temporary product risks (r = –.01). However, gain-
framed participants’ behavioral intentions exhibited a strong
negative correlation (r = –.47, p < .0001) with perceived per-
manent product risks. Meng, Rosenthal, and Rubin’s (1992)
test indicates that the difference between these two correla-
tions was statistically significant (z = 4.03, p < .0001).
Thus, as we predicted in H4, consumers exposed to
gain-framed messages appear to give significantly more
decisional weight to permanent product risks than to tempo-
rary product risks. In contrast, consumers exposed to loss-
framed messages respond equally negatively to both types
of product risk.
Discussion
Consumers are increasingly called on to evaluate product
risk (i.e., the possibility that product use may cause negative
consequences). However, there has been relatively little
research on how consumers evaluate product risk informa-
tion, and the research that exists has produced contradictory
findings. To help explain these contradictory findings, we
hypothesized that the persuasive effects of product risk
information may be moderated by message framing. Specif-
ically, we evaluated three competing theories of how fram-
ing and product risk may interact to influence consumer
product evaluations and intentions.
We evaluated function/risk theory (Meyerowitz and
Chaiken 1987; Rothman and Salovey 1997), which posits
that (1) loss-framed messages induce risk-seeking behavior,
whereas gain-framed messages induce risk-avoidance
behavior; (2) consumers perceive detection behaviors as
risky and prevention behaviors as low risk (or “safe”); and
(3) loss-framed messages increase consumers’ motivation to
use detection products, whereas gain-framed messages
increase consumers’ motivation to use prevention products.
None of these three premises was supported by our data.
First, although manipulation checks confirmed that con-
sumers understood the respective functions (detection ver-
sus prevention) of the two product concepts presented in
Study 1, participants did not perceive the detection product
as inherently riskier than a prevention product with the
same form and usage experience. Second, Study 1 did not
find any difference in message-framing effects between
detection and prevention products. Third, function/risk
theory’s most basic premise, that loss-framed messages
induce risk-seeking behavior, was contradicted by both
Studies 1 and 2. In both experiments, participants exposed
to loss-framed messages exhibited a general aversion to
product risk involving both relatively short-term adverse
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effects (Studies 1 and 2) and more permanent harm (Study
2). There was no evidence of risk-seeking behavior among
loss-framed participants in either experiment.
As we noted previously, proponents of function/risk
theory claim that their hypothesis of risk seeking among
people exposed to loss-framed messages is grounded in
Tversky and Kahneman’s (1981) prospect theory. In that
case, does our empirical disconfirmation of this hypothesis
mean that prospect theory is wrong? Absolutely not. It sim-
ply means that in the attempt to derive function/risk theory
from prospect theory, key aspects of prospect theory (partic-
ularly the meaning of the word “risk”) were lost in transla-
tion. As we noted previously, Tversky and Kahneman used
the word “risk” in a technical sense to mean the variance of
potential outcomes, so that a riskier option entails both
extremely positive and extremely negative possibilities
rather than a predictable (but mediocre) certain option.
When risk is operationalized in this way, participants are
sometimes motivated to choose the risky option because of
its positive possibilities. This is particularly true if outcomes
are framed as losses because the certain option then entails
a certain small loss, whereas the risky option offers the
upside possibility of no loss. Given this somewhat esoteric
definition of “risk,” risk-seeking behavior seems plausible.
However, although this “risk as variance” definition is
used in a few academic fields, including expected utility
theory (the point of departure for prospect theory) and
financial investment analysis, it does not match the way the
word “risk” is used by function/risk theorists or, for that
matter, in most academic disciplines. To most people, acad-
emic or layman, “risk” specifically connotes the possibility
of something bad. For example, Merriam-Webster (2005)
defines risk as “possibility of loss or injury: peril.” Simi-
larly, in a typical consumer behavior definition, Solomon
(2004, p. 304) defines perceived risk as “the belief that the
product has potentially negative consequences,” and risk
perception researcher Paul Slovic (2000) uses the words
“risk” and “hazard” interchangeably. In none of these cases
does “risk” imply the possibility of extremely positive con-
sequences that help explain Tversky and Kahneman’s
(1981) results.
Therefore, to understand how message framing might
influence consumers’ responses to product risk (defined as
potential negative consequences), we proposed two alterna-
tive theories: valence congruity theory and risk discrimina-
tion theory. Both theories are based on prior findings that
message framing influences mood and that mood influences
consumers’ responses to risk. Both theories suggest that
exposure to gain-framed messages increases consumers’ tol-
erance for temporary product risks, a finding that was con-
firmed in both Study 1 and Study 2. However, the theories
diverge in predicting how message framing will affect con-
sumers’ responses to more serious, long-lasting product
risks. Thus, Study 2 was designed to address this issue. The
findings of this experiment support risk discrimination
theory: Participants exposed to gain-framed messages
appear to be better able to discriminate between important
and unimportant risks; they essentially ignore minor or tem-
porary product risks but exhibit considerable caution
regarding the possibility of more permanent, serious risks.
In addition to their theoretical implications, our findings
may have implications for those who design and regulate
promotional messages for risky products, including DTC
advertisements for prescription drugs. Food and Drug
Administration requirements dictate that any DTC adver-
tisement that mentions a product’s brand name (e.g., Levi-
tra) and its benefits (improving male sexual function) must
disclose the product’s side-effect risks (e.g., severe
headaches). The only way to avoid such disclosure is to
either not name the product (e.g., “Ask your doctor about
new treatments for erectile dysfunction”) or not say what it
does (e.g., “Ask your doctor about Levitra”). Thus, DTC
advertisers must either mention product risks or produce
rather cryptic advertisements (e.g., the Levitra advertise-
ment that does not indicate what it does but shows a foot-
ball going through a swinging tire).
Although there has been relatively little research on how
consumers process such product risk information, there are
several theories. One theory (e.g., Goetzl 2000; Rodale
Publications 1999) is that product risk disclosures actually
enhance advertisement credibility by making the advertiser
seem more forthcoming. Another theory is that product risk
disclosures undermine the positive content of an advertise-
ment and reduce advertising persuasiveness (Goetzl 2001;
Morris, Mazis, and Brinberg 1989). However, our findings
do not support either of these simple main effects of prod-
uct risk. Instead, our data suggest that consumers respond
differently to product risk depending on both the nature of
this risk (temporary versus permanent) and the framing of
the persuasive message. Participants exposed to loss-framed
messages exhibited an aversion to product risk, whereas
those exposed to upbeat, gain-framed messages essentially
disregarded temporary product risks in forming product
evaluations and intentions.
These results suggest that advertisers are able to reduce
the decisional weight that consumers give to certain types
of product risk information by placing such information in
the context of upbeat, gain-framed message executions. If
confirmed by further research, this finding has potentially
important implications both for marketers required to
include product risk disclosures in their promotional materi-
als and for the consumer protection agencies that institute
these disclosure requirements.
To understand the policy implications of these findings
more fully, further research should explore several issues.
Specifically, further research should examine whether the
framing-induced optimism we observed in our study is ben-
eficial or harmful in general to consumer welfare. As we
noted previously, our research found that consumers
exposed to gain-framed messages gave essentially zero
weight to temporary product risks (i.e., skin rash or shot
pain) in evaluating a disease protection product (i.e., skin
cancer lotion or hepatitis vaccination). However, is this dis-
regard of temporary product risk a good thing or a bad
thing? On the one hand, in general, consumers should con-
sider risks before pursuing any course of action. On the
other hand, perhaps consumers should give the possibility
of a skin rash (or a sore shoulder) considerably less weight
than the chance to protect themselves from skin cancer or
liver disease. Perhaps optimism induced by gain-framed
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messages simply helps consumers overcome their natural
hesitancy toward taking calculated risks (i.e., the omission
bias). This is an important issue for further research.
Finally, further research should explore the emotional
effects of message framing, examining more broadly how
these effects may influence consumer judgment and deci-
sion making. As we noted previously, most message-
framing research to date has been grounded (at least osten-
sibly) in Kahneman and Tversky’s (1979; see also Tversky
and Kahneman 1981) prospect theory, which, as is the case
with much of behavioral decision theory, tends to empha-
size cognitive over affective phenomena (for a discussion of
the neglect of emotion in behavioral decision research, see,
e.g., Loewenstein et al. 2001). However, the finding that
message framing influences consumers’ moods, along with
the wealth of research showing that mood affects decision
making (e.g., Isen 2000), could open up entirely new
avenues in the study of framing effects. We strongly encour-
age researchers to explore those avenues.
Appendix
Examples of Experimental
Messages
Detection/Low Risk/Loss
Skin cancer is the most common form of cancer among
people in their twenties. Every 53 minutes, someone dies of
skin cancer. Skin cancer can be hard to see with the naked
eye or may look like a normal mole or freckle.
Fortunately, there is now a medicated lotion which can
detect skin cancer. This product is not a sunblock or sun-
screen. It is applied by a doctor to the patient’s skin and cre-
ates a gentle reaction, which allows the doctor to easily
detect the early development of skin cancer. This lotion is
highly effective and very safe.
If you fail to use this lotion, you will be losing an
opportunity to detect the development of skin cancer cells
before they can do serious harm. By failing to use this
lotion, you can significantly harm your chances of living a
long, cancer-free life.
For more information, call 1-800-4CANCER, or talk to
your doctor.
Prevention/High Risk/Gain
Skin cancer is the most common form of cancer among
people in their twenties. Every 53 minutes, someone dies of
skin cancer. Skin cancer can be hard to see with the naked
eye or may look like a normal mole or freckle.
Fortunately, there is now a medicated lotion which can
prevent skin cancer. This product is not a sunblock or sun-
screen. It is applied by a doctor to the patient’s skin and cre-
ates a gentle reaction, which allows the doctor to easily pre-
vent the early development of skin cancer. This lotion is
highly effective and generally safe. However, in some
patients, it can cause a severe skin rash lasting several
weeks.
If you use this lotion, you will be gaining an opportu-
nity to prevent the development of skin cancer cells before
they can do serious harm. By using this lotion, you can sig-
nificantly improve your chances of living a long, cancer-
free life.
For more information, call 1-800-4CANCER, or talk to
your doctor.
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